Monetizing music is not an easy task, but Splice is finding success cracking the code. Splice's Co-Founder, Steve Martocci, joined us to discuss how the company is developing a creative hub for modern musicians.
Splice isn't Martocci's first company. He founded GroupMe in 2010 and sold it to Skype in 2011. While he is taking on a different industry, he shares that he orignally created GroupMe with the intention to make it easier for friends to go to concerts together. Martocci says software has always been his canvas, and music is the motivator. The entrepreneur tells us how his experience with the messaging application is helping him in his latest venture.
Martocci explains that the app works for everyone from GRAMMY nominated artists to brand new musicians. In fact, a sound from Demi Lovato's hit song "Sorry Not Sorry," was sampled from the Splice platform. It's not just music. The platform is used for all types of audio, including cinema.
Splice just raised $35 million, bringing total funding to $47 million. While the company has made a lot of progress, Martocci says there is a lot more to do. With the new funding, he plans to build the best team possible.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.
Delta CSO Amelia DeLuca reveals at the Fast Co. Innovation Festival how tech, sustainable aviation fuel, and smart operations are revolutionizing air travel.
